Result
€68,733 €68,733
Back in profit in 2025, after a loss of €22,838 in 2024.
MM DERM
Lifetime
2 annual accounts with figures on one time axispeak €92,811 (2025)
€92,811▲ €115,613
lowest -€22,838 (2024)
€68,733▲ €91,572
peak €60,895 (2025)
€60,895▲ €68,733
€74,936▲ 237%
Board1 name since 2024
1 director
Documentsfilings and deeds
01-07-202630 days before the deadline
2025micro format
Gross margin from -€22,802 to €92,811Back to profit: €68,733Equity from -€7,838 to €60,895Debts from €22,221 to €74,936Investments €72,915Cash from €10,373 to €46,232
Key points
from the 2025 annual accountsTurnover
≈ €210,000 estimated
The micro format states no turnover.
Investments
€72,915 19.8 × depreciation
Green is investment, beige is depreciation.
Liquidity
2.17 was 0.64 in 2024
Short-term debts rose from €22,221 to €30,595.
Starting capital
€15,000 100 shares
At the same address
17 companies
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,326 companies had the same profile as MM DERM has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,326 companies, not a prediction for MM DERM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered office moved within Uccle
New registered office: Winston Churchilllaan 84, 1180 Ukkel · Previous registered office: Hagedoornlaan 10, 1180 Ukkel · General meeting of 01-05-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1010372685
Registered office moved from Saint-Gilles to Uccle
New registered office: Hagedoornlaan 10, 1180 Ukkel · Previous registered office: Ducpétiauxlaan 131 bus RC+1, 1060 Sint-Gillis · General meeting of 30-07-2024 · Gazette deed
Incorporation
Founding capital of €15,000, 100 shares · Founders: ; · Appointment: (director) · published on 18-06-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MM DERM Uccle | €135,831 | €92,811 | 44.8% | - |
| MV Healthcare Schaerbeek | €139,384 | €97,982 | 52.8% | - |
| SYNAPTIQUE Woluwe-Saint-Lambert | €137,613 | €92,783 | 82.0% | - |
| CASSIOPÉE MÉDICAL Etterbeek | €155,595 | €91,830 | 77.6% | - |
| SC MED Brussels | €142,085 | €101,640 | 93.4% | - |
| K. Callebaut Aalst | €129,516 | €96,953 | 66.6% | - |
| Résonnances Santé Andenne | €123,053 | €91,378 | 99.0% | - |
These companies have the same main activity as MM DERM: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €123,000 and €156,000, founded in 2024.
Official details
Source: KBO- Status
- Active since 14-06-2024Normal situation
- Registered office
- 19 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 15 November 2026.
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.360.623.2761180 Uccle, since 14-06-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 10-12-2025
Annual accounts 2025
- €135,831▲ 844%
- Filing
- Filed on 01-07-2026, 30 days before the end of the filing period
Insights on MM DERM
MM DERM has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €60,895 and a net result of €68,733.
Its solvency ranks better than 35% of 21,334 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MM DERM
- What is the company number of MM DERM?
- The company number of MM DERM is 1010.372.685. The VAT number is the same number with BE in front: BE 1010.372.685.
- Where is MM DERM based?
- The registered office is at Winston Churchilllaan 84, 1180 Uccle.Company details
- What does MM DERM do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of MM DERM?
- MM DERM is a private limited company (BV).
- When was MM DERM founded?
- MM DERM was founded on 14-06-2024.
- Is MM DERM still active?
- Yes, MM DERM is an active enterprise in the KBO register.
- What is the turnover of MM DERM?
- The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €92,811 and 34 comparable companies (NACE 862). It probably lies between €160,000 and €250,000.Financials
- Is MM DERM profitable?
- In financial year 2025, MM DERM made a profit of €68,733.
- Where can I find the annual accounts of MM DERM?
- MM DERM filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MM DERM due?
- MM DERM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.